register

News & Trends - Pharmaceuticals

AbbVie New Zealand welcomes new leadership as global moves unfold

Health Industry Hub | February 9, 2024 |

Pharma News: AbbVie has announced the appointment of Elhussein Abdellatif as the new Country Head for New Zealand. Reporting directly to Nathalie McNeil, Vice President and General Manager of AbbVie Australia & New Zealand, Hussein brings a wealth of experience and expertise to his new role.

Hussein takes over from Kylie Pennington, who has been at the helm of AbbVie New Zealand since May 2022. Kylie has been appointed General Manager for Skyrizi Dermatology, International Marketing & Commercial Operations (IMCO), reporting to Felipe Palacios, VP, Immunology, IMCO.

With a degree in Pharmaceutical Science from Ain Shams University in Egypt and over 18 years of industry experience spanning various roles and therapeutic areas, including Immunology, Oncology, Neuroscience, and HCV, Hussein is well-equipped to lead the New Zealand team.

Having been with AbbVie for nine years, Hussein initially joined AbbVie Saudi Arabia in 2015, progressing through the ranks. His most recent role was as the Oncology Commercial Director, Intercontinental, based in the US. Prior to joining AbbVie, Hussein gained valuable experience at MSD, Lundbeck, and Novartis, where he held roles in sales and marketing.

Ms McNeil expressed enthusiasm about Hussein’s appointment, stating, “We are excited to have Hussein join and lead the New Zealand team to build on the strong foundations already in place. His promotion, along with Kylie’s promotion to a global role, demonstrates AbbVie’s commitment to developing key talent and creating compelling career opportunities. We also thank Kylie for her leadership over the past two years in the Country Head role.”

Hussein officially assumed his new role last month and is currently in the process of relocating from Chicago to New Zealand with his family. In a parallel move, Kylie Pennington and her family are also relocating, making the journey from Auckland to Chicago.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.